Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 5Polycystic Ovary Syndrome 2Obesity 2Leukemia, Myeloid, Acute 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Triple Negative Breast Neoplasms 1Tracheal Diseases 1TP53 Y220C Mutation 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Overweight 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Motor Activity 1Mesothelioma 1Meningioma 1Medulloblastoma 1Lymphoma 1Lung Neoplasms 1Localized Prostate Cancer 1Leukemia 1Leiomyosarcoma 1

Interventions

mazdutide 1lithium sulfate 1lime 1fasudil 1blueberry extract 1Walking 1Transcranial Magnetic Stimulation 1Transcranial Direct Current Stimulation 1Therapeutics 1Tablets 1Radiotherapy 1Patient Reported Outcome Measures 1Organization and Administration 1Neuropsychological Tests 1Modafinil 1Methods 1Metformin 1Memantine 1Low-Level Light Therapy 1Lithium 1Infliximab 1Drug Therapy 1Data Collection 1Cognitive Behavioral Therapy 1Chemoradiotherapy 1Accidental Falls 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cognitive Dysfunction × Tablets × Clear all
NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting
140 enrolled
CNS

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡